Drug Type Small molecule drug |
Synonyms FR-900280 |
Target |
Action inhibitors |
Mechanism AKR1B1 inhibitors(Aldose reductase inhibitors), Oxidoreductases inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H20N2NaO8 |
InChIKeyJAPMHCAVRINUMT-UHFFFAOYSA-N |
CAS Registry128524-51-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Complications | Preclinical | - | - |